• Explore /
  • Poster
  • / Neoadjuvant pembrolizumab, GX-188E, and GX-I7 in patients with human papillomavirus-16- and/or 18-positive head and neck squamous cell carcinoma: Single-arm, phase 2 trial with single cell transcriptomic analysis and artificial intelligence-powered spatial analysis.

Neoadjuvant pembrolizumab, GX-188E, and GX-I7 in patients with human papillomavirus-16- and/or 18-positive head and neck squamous cell carcinoma: Single-arm, phase 2 trial with single cell transcriptomic analysis and artificial intelligence-powered spatial analysis.

Abstract Poster

Authors

Hye Ryun Kim

Hye Ryun Kim

Department of Internal Medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea

Hye Ryun Kim , Chang Gon Kim , June-Young Koh , Min Hee Hong , Hyun Jun Hong , DaHee Kim , Nam Suk Sim , Sun Och Yoon , Gamin Kim , Jung Eun Lee , Wonrak Son , Chang Lee , Kyung Hwan Kim , Jeong Seok Lee , Donggeun Yoo , Chan-Young Ock , Yoon Woo Koh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT05286060

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6075)

DOI

10.1200/JCO.2023.41.16_suppl.6075

Abstract #

6075

Poster Bd #

67

Abstract Disclosures

Similar Posters

First Author: Bernard Doger de Spéville

First Author: Jared Weiss

First Author: Nicholas Coupe

First Author: Hsiang-fong Kao